Ignite Creation Date:
2024-10-26 @ 3:35 PM
Last Modification Date:
2024-10-26 @ 3:35 PM
Study NCT ID:
NCT06505122
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-07-10
Brief Title:
Dyadic Life Review Intervention for Older Patients With Advanced Cancer and Their Caregivers
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A Pilot Randomized Controlled Trial RCT of a Dyadic Life Review Intervention for Older Patients With Advanced Cancer and Their Caregivers
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
DLR RCT
Brief Summary:
The purpose of this study is to test the feasibility of a pilot Randomized Controlled Trial RCT comparing Dyadic Life Review DLR intervention in older adults with advanced cancer and their caregivers to Care-as-Usual CAU group which involves a referral to social work
Detailed Description:
The purpose of this study is to test the feasibility of a pilot Randomized Controlled Trial RCT comparing Dyadic Life Review DLR intervention in older adults with advanced cancer and their caregivers to Care-as-Usual CAU group which involves a referral to social work The study will enroll dyads pairs of caregivers and older patients with advanced cancer and dyads of caregivers and patients with advanced cancer A previous single-arm study was performed testing the feasibility of the adapted DLR intervention in older adults with advanced cancer and their caregivers The single-arm pilot demonstrated DLR was feasible and acceptable by both patients and caregivers This innovative pilot study will gather data to test the feasibility of a pilot and examine pre-post intervention changes in caregiver psychological distress
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None